IRIS - Res&Arch Institutional Research Information System - Research & Archive

PACIOTTI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.944
EU - Europa 1.376
AS - Asia 1.361
SA - Sud America 233
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 37
OC - Oceania 2
Totale 5.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.887
SG - Singapore 638
IT - Italia 311
IE - Irlanda 247
CN - Cina 211
BR - Brasile 178
HK - Hong Kong 175
FR - Francia 167
VN - Vietnam 161
RU - Federazione Russa 157
DE - Germania 99
UA - Ucraina 78
SE - Svezia 54
FI - Finlandia 52
RO - Romania 51
GB - Regno Unito 47
CA - Canada 29
TR - Turchia 24
IN - India 22
AR - Argentina 20
BD - Bangladesh 19
MX - Messico 18
KR - Corea 17
PL - Polonia 17
BE - Belgio 16
IQ - Iraq 16
NL - Olanda 15
JP - Giappone 14
AT - Austria 10
CZ - Repubblica Ceca 10
ES - Italia 10
ZA - Sudafrica 9
CH - Svizzera 8
EC - Ecuador 8
PK - Pakistan 8
GR - Grecia 7
CL - Cile 6
CO - Colombia 6
ID - Indonesia 6
UZ - Uzbekistan 6
KE - Kenya 5
NP - Nepal 5
PH - Filippine 5
SA - Arabia Saudita 5
VE - Venezuela 5
DZ - Algeria 4
LB - Libano 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
DK - Danimarca 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
PY - Paraguay 3
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CG - Congo 2
EG - Egitto 2
ET - Etiopia 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
BJ - Benin 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.955
Salva come PNG Salva come JPEG
Città #
Singapore 484
Chandler 268
Dublin 247
San Jose 197
Perugia 173
Hong Kong 171
Ashburn 119
San Mateo 104
Beijing 87
Ann Arbor 68
Santa Clara 68
Dong Ket 67
Altamura 59
Boardman 59
Moscow 57
Bucharest 49
Wilmington 46
Lauterbourg 44
Medford 44
Princeton 44
Los Angeles 40
Jacksonville 38
Lawrence 38
Ho Chi Minh City 37
New York 35
The Dalles 33
Munich 29
Andover 26
São Paulo 25
Des Moines 24
Hanoi 24
Redmond 21
Seoul 17
Frankfurt am Main 16
Helsinki 16
Brussels 15
Nuremberg 15
Orem 14
Chennai 13
Council Bluffs 13
Dallas 13
Denver 13
Houston 13
Saint Petersburg 13
Warsaw 13
Brooklyn 12
Tokyo 12
Montreal 11
Turku 11
Phoenix 10
Redwood City 10
Seattle 10
Amsterdam 9
London 9
Mexico City 9
Stockholm 9
Chicago 8
Norwalk 8
Izmir 7
Milan 7
San Paolo di Civitate 7
Baghdad 6
Buffalo 6
Johannesburg 6
Manchester 6
Olomouc 6
Piscataway 6
Shanghai 6
Woodbridge 6
Ankara 5
Atlanta 5
Fairfield 5
Falls Church 5
Istanbul 5
Nairobi 5
Tashkent 5
Belo Horizonte 4
City of London 4
Florence 4
Guangzhou 4
Guayaquil 4
Lappeenranta 4
Rome 4
St Louis 4
Vancouver 4
Vienna 4
Amman 3
Cambridge 3
Curitiba 3
Da Nang 3
Den Haag 3
Falkenstein 3
Joinville 3
Lahore 3
Nicosia 3
Ninh Bình 3
Philadelphia 3
Poplar 3
Quezon City 3
San Francisco 3
Totale 3.323
Salva come PNG Salva come JPEG
Nome #
CSF and blood biomarkers for Parkinson's disease 204
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 174
Accumulation of free oligosaccharides and tissue damage in cytosolic alpha-mannosidase (Man2c1)-deficient mice. 157
First pilot newborn screening for our lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene 139
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 134
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 132
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 131
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 128
di-N-acetylchitobiase-deficient mice accumulate Man2GlcNAc2 and Man3GlcNAc2 126
Generation of a chitobiase knock out mouse model 125
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 125
Lysosomal alpha-mannosidase and alpha-mannosidosis 123
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 123
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 121
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 121
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 116
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 116
Identification of two novel beta-mannosidosis-associated sequence variants: biochemical analysis of beta mannosidase (MANBA) missense mutations. 114
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 114
Lysosomal di-N-acetylchitobiase-deficient mouse tissues accumulate Man2GlcNAc2 and Man3GlcNAc2 113
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 110
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 109
Free oligosaccharides accumulation and tissue damages in Ma2c1 deficient mice 105
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 105
Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma 104
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 104
Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs) 100
Lysosomal enzymes in Parkinson's disease 100
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 96
Biochemical analysis of missense mutations in beta-mannosidosis 93
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes 91
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 87
Parkinson's and Lewy body dementia CSF biomarkers 86
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 85
Emerging therapies and therapeutic concepts for lysosomal storage diseases 84
Origin of α-mannosidase activity in CSF 84
Lysosomal enzymes in PD: further evidence is needed. 81
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 80
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 77
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 77
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 76
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 76
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease 70
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 69
Next generation sequencing applications in agro biotechnology 69
Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer's disease 67
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 56
Totale 5.110
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022488 0 78 7 11 7 19 6 107 37 51 74 91
2022/2023841 51 160 15 74 62 92 0 32 312 1 31 11
2023/2024300 27 26 25 6 2 1 75 14 20 14 46 44
2024/2025753 4 56 29 41 78 50 41 38 160 57 135 64
2025/20261.802 108 100 79 248 265 183 301 80 232 143 46 17
2026/202778 43 35 0 0 0 0 0 0 0 0 0 0
Totale 5.110